Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiebert

Showing results (861-870 of 888) with videos related to

Pageof 89
Sort By:
Nature Communications|November 24, 2019
Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesityMercedes Dávalos-Salas, Magdalene K Montgomery, Camilla M Reehorst, et al.
JCI Insight|May 3, 2022
MTG16 regulates colonic epithelial differentiation, colitis, and tumorigenesis by repressing E protein transcription factorsRachel E Brown, Justin Jacobse, Shruti A Anant, et al.
BMJ Open|November 5, 2017
Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort studyKevin F Boreskie, D Scott Kehler, Eduardo C Costa, et al.
Chemmedchem|July 4, 2014
4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distributionJennifer X Qiao, Tammy C Wang, Sheldon Hiebert, et al.
Gut|July 27, 2012
MTG16 contributes to colonic epithelial integrity in experimental colitisChristopher S Williams, Amber M Bradley, Rupesh Chaturvedi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2023
Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcomaMartyna W Sroka, Damianos Skopelitis, Marit W Vermunt, et al.
Science Translational Medicine|March 13, 2020
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitorsJohanna M Schafer, Brian D Lehmann, Paula I Gonzalez-Ericsson, et al.
JCI Insight|August 18, 2017
MTG16 is a tumor suppressor in colitis-associated carcinomaElizabeth M McDonough, Caitlyn W Barrett, Bobak Parang, et al.
Environmental Science & Technology|February 10, 2022
In Situ Enhancement and Isotopic Labeling of Biogenic Coalbed MethaneElliott P Barnhart, Leslie F Ruppert, Randy Hiebert, et al.
Cell Reports|March 14, 2019
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar AffinityErin R Aho, Jing Wang, Rocco D Gogliotti, et al.
Pageof 89

Showing results (861-870 of 888) with videos related to

Sort By:
Pageof 89
Nature Communications|November 24, 2019
Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesityMercedes Dávalos-Salas, Magdalene K Montgomery, Camilla M Reehorst, et al.
JCI Insight|May 3, 2022
MTG16 regulates colonic epithelial differentiation, colitis, and tumorigenesis by repressing E protein transcription factorsRachel E Brown, Justin Jacobse, Shruti A Anant, et al.
BMJ Open|November 5, 2017
Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort studyKevin F Boreskie, D Scott Kehler, Eduardo C Costa, et al.
Chemmedchem|July 4, 2014
4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distributionJennifer X Qiao, Tammy C Wang, Sheldon Hiebert, et al.
Gut|July 27, 2012
MTG16 contributes to colonic epithelial integrity in experimental colitisChristopher S Williams, Amber M Bradley, Rupesh Chaturvedi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2023
Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcomaMartyna W Sroka, Damianos Skopelitis, Marit W Vermunt, et al.
Science Translational Medicine|March 13, 2020
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitorsJohanna M Schafer, Brian D Lehmann, Paula I Gonzalez-Ericsson, et al.
JCI Insight|August 18, 2017
MTG16 is a tumor suppressor in colitis-associated carcinomaElizabeth M McDonough, Caitlyn W Barrett, Bobak Parang, et al.
Environmental Science & Technology|February 10, 2022
In Situ Enhancement and Isotopic Labeling of Biogenic Coalbed MethaneElliott P Barnhart, Leslie F Ruppert, Randy Hiebert, et al.
Cell Reports|March 14, 2019
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar AffinityErin R Aho, Jing Wang, Rocco D Gogliotti, et al.
Pageof 89